RxDoctor Payments Data

Mrinal Mullick, MD

Psychiatry · Bowling Green, KYNPI 1174524250

Payments from drug & device makers

$299in general payments, 2019–2025

Across 11 payments — averaging $27.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corium, LLC$132
  • Teva Pharmaceuticals USA, Inc.$50
  • AbbVie$47
  • Supernus Pharmaceuticals, Inc.$21
  • Lundbeck LLC$18
  • Ironshore Pharmaceuticals Inc.$17
  • plus $15 from 1 others

What the payments were for

  • Food & beverage$299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$299 in reported general payments places this provider in the 45th percentile of 348 psychiatry providers in Kentucky.

See all psychiatry providers in Kentucky

Medicare billing

Part B allowed, 2024
$120,507
Medicare patients
177
Services billed
1,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl53$84,309
Abilify MaintenaAripiprazole13$28,096
CaplytaLumateperone Tosylate13$20,531
Atomoxetine Hcl66$11,789
TrintellixVortioxetine Hydrobromide19$11,743
Aripiprazole209$7,485
Clozapine64$3,700
Venlafaxine Hcl ErVenlafaxine Hcl63$3,653
Buspirone Hcl280$3,229
Lamotrigine222$3,220
Duloxetine Hcl186$3,171
Quetiapine Fumarate154$2,449
Trazodone Hcl246$2,260
Sertraline Hcl258$2,252
Olanzapine73$2,204

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$47$84,30953 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$15$28,09613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 348 psychiatry providers in Kentucky.

Other psychiatry in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →